Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SPRUCE BIOSCIENCES, INC. Director's Dealing 2024

Jan 3, 2024

35408_dirs_2024-01-03_c5abc921-2a03-4720-8e91-d98e5399209b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SPRUCE BIOSCIENCES, INC. (SPRB)
CIK: 0001683553
Period of Report: 2023-12-29

Reporting Person: Gharib Samir M. (President & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-29 Common Stock A 11255 $0.9775 Acquired 202776 Direct

Footnotes

F1: Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code.